Categories AlphaGraphs, Earnings, Health Care
BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the second quarter of 2023.
Total revenue declined 5% year-over-year to $2.46 billion. For the full year of 2023, the company expects revenues to decline in the mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.
Net income attributable to Biogen Inc. was $591.6 million or $4.07 per share in Q2, compared to $1.06 billion or $7.24 per share last year. Adjusted earnings declined 23% to $4.02 per share.
Prior Performance
Most Popular
Dollar Tree (DLTR): Key points of note from the Q3 2024 earnings report
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 2% on Wednesday after the company delivered better-than-expected earnings results for the third quarter of 2024. The discount retailer beat estimates
FL Earnings: Foot Locker Q3 2024 adj. profit rises; sales down 1%
Foot Locker, Inc. (NYSE: FL), a leading footwear and apparel retailer, reported an increase in adjusted profit for the third quarter of 2024 and a modest decrease in sales. Net sales
Infographic: How The Campbell’s Company (CPB) performed in Q1 2025
The Campbell's Company (NASDAQ: CPB) reported net sales of $2.8 billion for the first quarter of 2025, up 10% from the same period a year ago. Organic sales decreased 1%.
